Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-005312
Filing Date
2025-02-07
Accepted
2025-02-07 09:24:56
Documents
95

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 4146513
2 forms-1a_001.jpg GRAPHIC 19091
3 ex4-29.htm EX-4.29 130867
4 ex23-1.htm EX-23.1 3749
  Complete submission text file 0001493152-25-005312.txt   15815320

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aim-20240930.xsd EX-101.SCH 82835
6 XBRL CALCULATION FILE aim-20240930_cal.xml EX-101.CAL 88486
7 XBRL DEFINITION FILE aim-20240930_def.xml EX-101.DEF 405264
8 XBRL LABEL FILE aim-20240930_lab.xml EX-101.LAB 621912
9 XBRL PRESENTATION FILE aim-20240930_pre.xml EX-101.PRE 504590
99 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 3137630
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-284443 | Film No.: 25599562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)